- Supported exchanges /
- KQ /
- 354200.KQ
NGeneBio Co. Ltd. (354200 KQ) stock market data APIs
NGeneBio Co., Ltd. develops in vitro diagnostics companion diagnostics products and bioinformatics software. It offers BRCAaccuTest and BRCAaccuTest PLUS are reagent kits for breast and ovarian cancer, and hereditary breast and ovarian cancer syndrome; HEMEaccuTest, a clinical NGS kit for hematological malignancies, such as acute myeloid leukemia, acute lymphoid leukemia, myelodysplastic/myeloproliferative neoplasm, multiple myeloma, and lymphoma; SOLIDaccuTest, a genetic variants screening for solid tumors; HLAaccuTest, an in vitro diagnostic medical device for human leukocyte antigen typing; and OncoaccuPanel, a solid tumor oncology next generation sequencing test. The company also provides NGeneAnalySys, a software for analysis of the genetic testing data; and EasyHLAanalyzer, which offers the HLA typing identifing human leukocyte antigen for histocompatibility antigens using data from NGS. In addition, it offers IDaccuTest, a short tandem repeat test for family relationship testing, identity testing, forensics, and chimerism analysis; and NGenePlex nCoV qRT-PCR Kit, a reagent of real-time reverse transcription-polymerase chain reaction assay intended for the qualitatively detecting nucleic acid of SARS-CoV-2 from patients infected or suspected of COVID-19. The company was founded in 2015 and is headquartered in Seoul, South Korea.
NGeneBio Co. Ltd. Financial Data Overview
| 2655 | |
| 2670 | |
| - | |
| 2755 | |
| 2590 | |
| 2062.9929-6964.9669 | |
| 38 544 M | |
| 14 518 K | |
| 4 989 M | |
| -175.0267 | |
| 1.185 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
NGeneBio Co. Ltd. Fundamental Data is available in our Financial Data APIs
- Net Revenue 4 989 M
- EBITDA -11 795 364 864
- Earnings Per Share
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get NGeneBio Co. Ltd. Earnings via APIs
- Latest Release 2024-06-30
- EPS/Forecast NaN
Get NGeneBio Co. Ltd. End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
